China Health Group Ltd
HKEX:673
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (10.2), the stock would be worth HK$-0.45 (178% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -13 | HK$0.57 |
0%
|
| Industry Average | 10.2 | HK$-0.45 |
-178%
|
| Country Average | 12.7 | HK$-0.56 |
-198%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| HK |
|
China Health Group Ltd
HKEX:673
|
721.3m HKD | -13 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 23.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 36.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 35.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 11.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 20.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 21.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 12.7 |
| 70th Percentile | 19.3 |
| Max | 6 260.9 |
Other Multiples
China Health Group Ltd
Glance View
China Health Group Ltd. operates as an investment holding company. The company employs 131 full-time employees The firm mainly operates its business through four segments. The Trading of Medical Equipment And Consumables segment engages in the medical equipment trading business and trading of medical consumables business. The Hospital Management Service segment is engaged in the operation of Shuangluan Hospital, Anping Bo’ai Hospital, Red Cross Hospital of Luanping County and the Hong Fu Eldercare and Nursing Home of Luanping County, among others. The Property Investment segment is engaged in acquisition of properties of Anping Bo’ai Hospital and generate rental income. The Business Factoring segment operates business factoring business for hospitals.
